RetractedArticleBioengineered2022

Dihydroartemisinin targets fibroblast growth factor receptor 1 (FGFR1) to inhibit interleukin 17A (IL-17A)-induced hyperproliferation and inflammation of keratinocytes.

Baojiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.